WO1994017852A1 - An implantable electrode - Google Patents

An implantable electrode Download PDF

Info

Publication number
WO1994017852A1
WO1994017852A1 PCT/US1993/005777 US9305777W WO9417852A1 WO 1994017852 A1 WO1994017852 A1 WO 1994017852A1 US 9305777 W US9305777 W US 9305777W WO 9417852 A1 WO9417852 A1 WO 9417852A1
Authority
WO
WIPO (PCT)
Prior art keywords
implantable electrode
electrode according
helically wound
electrically conductive
wound conductor
Prior art date
Application number
PCT/US1993/005777
Other languages
French (fr)
Inventor
Thomas M. Soukup
Richard A. Staley
Original Assignee
W.L. Gore & Associates, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by W.L. Gore & Associates, Inc. filed Critical W.L. Gore & Associates, Inc.
Priority to CA002152604A priority Critical patent/CA2152604C/en
Priority to JP6504456A priority patent/JPH08505539A/en
Priority to DE69326080T priority patent/DE69326080T2/en
Priority to EP93916575A priority patent/EP0681494B1/en
Publication of WO1994017852A1 publication Critical patent/WO1994017852A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • A61N1/056Transvascular endocardial electrode systems
    • A61N1/0565Electrode heads

Definitions

  • This invention relates to the field of implantable electrodes and in particular transvenous defibrillator leads and heart pacer sensing leads.
  • Transvenous defibrillator leads are useful for the correction of ventricular tachycardia and ventricular fibrillation.
  • Leads of this type are intravenously positioned so that the electrode portion of a lead is located within the right side of the heart.
  • the lead may have only a single conductive electrode surface at or near the distal tip of the lead which is intended to be used in conjunction with an additional, separate and independent electrode such as a patch electrode located subcutaneously on the left side of the body.
  • the transvenous defibrillator lead may incorporate two separate electrodes at or near the distal tip of the lead which may be used in conjunction to deliver electrical energy to the heart. More than two electrodes may be provided within the distal tip portion if it is desired to provide electrodes for sensing as well as for delivering electrical energy.
  • Conventional transvenous defibrillator leads use a helically wound wire to conduct the electrical energy from the connector at the proximal end of the lead to the electrode at the distal end.
  • Multiple conductor wires typically are in the form of separate helically wound wires in coaxial relationship wherein each wire is separated from an adjacent wire by a tubular insulating layer. Alternatively they may be in the form of a co-linear helical winding wherein the individual wires are individually insulated prior to winding into a single helical form.
  • the conductive electrode surface is most commonly provided by leaving a length of the helically wound wire uninsulated and exposed to allow it to be exposed to the interior surface of the heart. While using the helically wound wire has the advantage of eliminating a connection between a separate electrode and the conductor wire, it has a fundamental disadvantage in that tissue grows into the exposed helically wound wire over time with the result that the lead can be extremely difficult to remove by the application of tension to the proximal end of the lead.
  • U. S. Patent 5,090,422 describes the use of a porous covering for use over the electrode surface wherein the covering is made of a biocompatible material which may be an insulating material but becomes conductive by virtue of penetration of the material by conductive body fluids.
  • the porous covering is of adequately small pore size to preclude substantial tissue ingrowth.
  • Recommended materials include woven, porous polyurethane and porous polytetrafluoroethylene if used with a wetting agent or surface modifier.
  • the present invention is an implantable electrode which comprises a helically wound conductor having an electrically conductive polymeric layer coaxially surrounding and contacting the helically wound conductor, wherein the electrically conductive polymeric layer is electrically conductive in a dry state prior to implantation.
  • the implantable electrode is primarily useful for transferring high levels of electrical energy for defibrillation to interior surfaces of a living heart, for example as the electrode portion of a transvenous defibrillator lead.
  • the implantable electrode is also useful for transferring much lower levels of electrical energy, for example, sensing signal levels as required by pacing systems.
  • the implantable electrode is preferably connected to a source of electrical energy by an appropriate length of insulated wire.
  • the helically wound conductor portion of the insulated wire is preferably continuous with the helically wound conductor that is coaxially covered by the electrically conductive polymeric layer and thereby forms the electrode surface that transfers energy to the heart.
  • the helically wound conductor can therefore be said to have a first lengt portion that is coaxially covered by an electrically conductive polymeric layer, hereinafter termed the conductive portion, and a second length portion that is coaxially covered by an electrically insulating layer, hereinafter termed the insulating portion.
  • the insulating layer coaxially covering the second length portion of the helically wound conductor is required to be made of an impermeable polymeric electrically insulating material such as silicone in order that the helically wound conductor is electrically isolated from contact with body fluids.
  • Impermeable is used herein to describe a material that is substantially impervious to the transfer of ions across the thickness of the material.
  • the insulating laye of impermeable polymeric electrically insulating material has an additional coaxial covering that provides the exterior surface of the insulated wire, the additional coaxial covering being porous polytetrafluoroethylene (hereinafter PTFE) of small pore size in orde to substantially preclude tissue ingrowth into the void spaces of the porous PTFE.
  • PTFE porous polytetrafluoroethylene
  • the electrically conductive polymeric layer which comprises the coaxial covering of the conductive portion and is intended as the surface material that transfers electrical energy to the heart, is preferably made of porous PTFE containing a carbon filler. This material is electrically conductive in a dry state prior to implantation and also offers good biocompatibility.
  • the electrically conductive polymeric layer may be of tubular form or alternatively ma be in the form of a tape that is helically wrapped about the surface of the first length portion of the helically wound conductor.
  • the helically wound conductors are preferably MP35N stainless steel-nickel alloy and most preferably are wound from a wire made as drawn, filled tube in the form of a silver core having an exterior surface coating of MP35N alloy. This type of conductor offers very good conductivity without exposing the silver conductor core to possible undesirable biological contact.
  • the implantable electrode of the present invention may be made with more than two electrodes by locating the electrodes sequentially along the length of the distal end of the implantable electrode. The electrodes are separated axially by lengths of insulating material such as silicone. The individual electrodes are supplied with electrical energy by individual helical wound conductors insulated from each other in either coaxial or co-linear relationship. The term co-linear describes a relationship wherein two or more individually insulated conductors are wound parallel to each other within the same helix.
  • Conventional connectors may be used to terminate the proximal end of the insulating portion for connection to a defibrillator energy source.
  • porous PTFE used in various portions of the construction of the inventive implantable electrode is preferably porous expanded PTFE which for the purpose of this invention is herein defined as porous PTFE having a microstructure of nodes interconnected by fibrils.
  • Porous expanded PTFE is described by and made according to the teachings of U. S. Patents 4,187,390 and 3,953,556.
  • the porous PTFE containing a carbon filler used for the surface of the conductive portion of the electrode is preferably porous expanded PTFE made according to the teachings of U. S. Patents 4,096,227; 4,187,390; 4,985,296 and 5,148,806.
  • Figure 1 describes a perspective view of an implantable electrode of the present invention incorporating a single conductive portion.
  • Figures 2 and 2A describe alternative cross sections of the implantable electrode of Figure 1.
  • Figure 3 describes a perspective view of a preferred embodiment of the implantable electrode incorporating two conductive portions.
  • Figure 4 describes a cross section of the implantable electrode of
  • Figure 4A describes an alternative embodiment to the implantable electrode shown by Figure 4 wherein the insulating portion has an exterior layer of porous polymeric material with an underlying layer of impermeable polymeric insulating material.
  • Figure 5 describes a cross section of an alternative to the embodiment of Figures 3 and 4 incorporating a different tip construction.
  • Figure 6 describes a cross section of an alternative to the embodiment of Figure 3 wherein the porous PTFE insulating material and the porous PTFE conductive material are secured to the surface of the helically wound conductor by a layer of a adhesive.
  • Figure 7 describes a cross section of an alternative to the embodiment of Figure 3 wherein the two helically wound conductors within the insulating portion are in co-linear relationship.
  • Figure 8 is a schematic view of the implantable electrode of the present invention in use with a human heart.
  • Figure 1 shows the implantable electrode 1Q of the present invention having an insulating portion 21. a conductive portion 21 and a conventional connector H terminating the proximal end of the electrode JO.
  • electrical energy is supplied to the conductive portion 13 by a helically wound conductor 3L
  • the insulating material 13 coaxially covering the insulating portion 21 is comprised of a layer of impermeable polymeric electrically insulating material such as silicone tubing.
  • the conductive portion 22 is comprised of an electrically conductive polymeric layer 15 which is electrically conductive in a dry state prior to implantation.
  • the electrically conductive polymeric layer 15 is in direct electrical contact with the helically wound conductor 31 that supplies electrical energy to the conductive portion 23.
  • This electrically conductive polymeric layer 15 is preferably comprised of a helically wrapped, porous PTFE tape containing a carbon filler wherein adjacent edges of the tape are overlapping.
  • the porous PTFE containing a carbon filler is required to be of small pore size such as less than about 10 microns in order to limit tissue ingrowth.
  • the distal end of this embodiment is covered by a cap 16 of either electrically conductive or electrically insulating material intended to close off the end of the tubular construction of the electrode J_0.
  • the use of an electrically conductive polymeric material as the tissue contacting portion of the electrode is a significant improvement over conventional transvenous defibrillator leads relying on direct contact between an exposed portion of a helically wound conductor and living tissue.
  • the difficulty with these conventional transvenous defibrillator leads is that over time tissue grows into the exposed portion of the helically wound conductor with the result that it becomes very difficult to withdraw the lead by applying traction to the proximal end.
  • the conductive portion 2 of the present invention is either non-porous or alternatively of a porous material having a pore size adequately small to substantially preclude tissue ingrowth. Adequately small pore sizes are typically of 10 micron diameter or smaller.
  • Porous PTFE and particularly porous expanded PTFE are preferred materials for the exterior surfaces of both the insulating portion 21 and conductive portion 22 because the porous PTFE is a chemically inert material with a long history of use in implantable medical devices and is well known to produce very little adverse tissue reaction. Additionally, the porous nature of the material allows the implantable electrode to be highly flexible and kink resistant.
  • the conductive porous PTFE for use as the electrically conductive polymeric layer that comprised the surface of the conductive portion 2 may be manufactured by uniformly distributing an electrically conductive filler throughout the porous PTFE during the process of making the porous PTFE layer.
  • the electrically conductive particulate may be blended with the powdered PTFE resin prior to extrusion and expansion.
  • Pore size of porous expanded PTFE is generally described as a function of the fibril length of the material. The fibril length of porous expanded PTFE is measured as taught by U. S. Patent 4,972,846 except that a sample magnification level greater than 100X may be necessary.
  • Figure 2A describes an alternative embodiment wherein an additional relatively short length of a helically wound conductor 32 is fitted coaxially over the distal end of the first helically wound conductor 31 for the length of the conductive portion 23. At least a portion of the additional relatively short length of helically wound conductor 32 is in direct electrical contact with the first helically wound conductor 3_1.
  • the use of the additional relatively short length of helically wound conductor 3_2 allows for a more corrosion resistant metal surface to which the electrically conductive polymer coaxial covering may be fitted.
  • a preferred metal for the additional relatively short length of helically wound conductor 32 is titanium.
  • Figure 3 shows a perspective view of a preferred embodiment of the implantable electrode of the present invention incorporating two conductive portions 2 and 19.
  • the first conductive portion 21 is comprised as described previously of a layer J_5 of electrically conductive polymeric material in contact with the first helically wound conductor 11.
  • the second conductive portion 1_9 is located at the distal tip of the implantable electrode 10 and is preferably comprised of conventional metallic electrode materials such as platinum, carbon or titanium and may optionally incorporate a means for passively or positively attaching to a tissue surface, such as a barb, tine or screw thread.
  • the second conductive portion 19 is connected to a second helically wound conductor H which is located coaxially within the lumen of the first helically wound conductor 3!
  • impermeable tubular electrically insulating layer 22 which is preferably silicone tubing.
  • the first and second conductive portions 23 and 19 are separated axially by a segment of impermeable polymeric electrically insulating material J_7 at the surface of the distal end of the electrode 10.
  • Figure 4A describes a cross section of an alternative embodiment to that described previously by Figure 4.
  • the insulating layer of Figure 4A is comprised of separate inner and outer layers.
  • Outer layer 41 is a coaxial covering of porous PTFE which is preferably porous expanded PTFE.
  • the inner layer 41 is an impermeable polymeric electrically insulating layer.
  • porous PTFE for the exterior surface of the insulating portion 21 requires the use of an underlying impermeable polymeric electrically insulating layer 41.
  • the impermeable polymeric electrically insulating layer may be any suitable material and may also serve as an adhesive to secure the exterior porous insulating material to the underlying electrical conductor. Suitable materials include silicone tubing, silicone adhesive, and fluoropolymer tubing or tapes that may be helically wrapped about the surface of the electrical conductor.
  • Figure 5 describes an alternative embodiment to those described previously by Figure 3 and Figure 4 wherein only the impermeable insulating tubular layer 21 separates the two electrodes at the surface of the implantable electrode 1_0.
  • the additional layer of porous PTFE insulating material J_7 described previously in the embodiment of Figure 4 is omitted in this instance.
  • Figure 6 shows a section of an alternative embodiment of the type described previously in Figures 3 and 4 wherein the porous PTFE .
  • insulating material 41 comprising the surface of the insulating portion 21 of the implantable electrode 10 is secured to the helically wound conductor 31 by a layer of adhesive 41 which may optionally serve as the impermeable electrically insulating layer if the adhesive characteristics meet those requirements.
  • the adhesive is preferably a thermoplastic adhesive which is preferably a fluoropolymer and most preferably FEP.
  • the adhesive securing the porous PTFE insulating material 41 may be either continuous as shown by layer 4_l or alternatively may be discontinuous. If the adhesive layer is discontinuous, the use of a separate impermeable electrically insulating layer will be required.
  • the electrically conductive polymeric material J> may also be secured by a layer of adhesive 46 which should be discontinuous in order to allow for good electrical contact with the helically wound conductor 3J,. Alternatively the layer of adhesive 46 may be an electrically conductive adhesive and therefore may be applied continuously.
  • non-conductive adhesive is a dispersion of water, fluorinated ethylene propylene (hereinafter FEP) in the form of a particulate and a surfactant, available from DuPont (Wilmington, DE) under the product name Teflon® FEP 120 Aqueous Dispersion.
  • FEP fluorinated ethylene propylene
  • Teflon® FEP 120 Aqueous Dispersion It has surprisingly been found that a thin layer of non-conductive polymeric adhesive produces good adhesion with little additional electrical resistance.
  • conductive fillers such as carbon black may be added to this dispersion in order to make it electrically conductive.
  • Six percent acetylene black Shawinigan Acetylene Black, Gulf Canada Ltd., Montreal, Quebec, Canada
  • This dispersion with and without acetylene black has been found useful to adhere the electrically conductive polymeric material of the electrode surface to the underlying helically wound conductor.
  • the porous PTFE may be made in sheet form having a layer of either continuous or discontinuous thermoplastic adhesive applied to one side of the porous PTFE sheet.
  • the composite may then be slit into relatively narrow lengths of tape for subsequent helical wrapping about the conductor wire surface with the adhesive side of the composite contacting the conductor and the porous PTFE side facing outwardly.
  • the helically wrapped conductor may then be heated to a temperature above the melt point of the thermoplastic adhesive to cause effective bonding of the composite tape to the conductor surface.
  • the process of making the porous PTFE material having a layer of either continuous or discontinuous thermoplastic adhesive comprises: a) contacting a porous PTFE substrate, usually in the form of a membrane of film, with a layer, usually a film of a thermoplastic polymer; b) heating the composition obtained in step a) to a temperature above the melting point of the thermoplastic polymer; c) stretching the heated composition of step b) while maintaining the temperature above the melting point of the thermoplastic polymer; and d) cooling the product of step c).
  • the thermoplastic film can form a very thin, i.e., 9 micron or less thick, film on the surface o the expanded porous PTFE which is continuous and non-porous. Or, if the degree of stretching is great enough, the thermoplastic film will eventually rend and form rents.
  • the rents are usually slit-like openings if the thermoplastic film is initially relatively thick, or are usually wider gaps or holes if the thermoplastic film is initially relatively thin. Such a film having gaps or holes is herein considered to be discontinuous.
  • the thermoplastic film is preferably a fluoropolymer and most preferably FEP.
  • the completed film may be slit into lengths of narrow tape for subsequent helical wrapping about the surface of an electrical conductor.
  • FIG. 6 describes the porous PTFE insulating material 41 as being in the form of a continuous tube and the electrically conductive polymeric material Jj> as being in the form of a helically wrapped tape, it is apparent that either continuous tubes or helically wrapped tapes may be used to provide the surface material for either the insulative portion 21 or the electrically conductive portion 21- Both the continuous tube covering and the helically wrapped covering may be secured as described by the thermoplastic adhesive.
  • Figure 7 describes a cross section of an alternative to the embodiment of Figure 3 wherein the first 11 and second H helically wound conductors within the insulating portion are in co-linear relationship wherein the two insulated conductors are wound parallel to each other within the same helix.
  • the first H and second H helically wound conductors are separately insulated wherein the first conductor H has a layer of insulation 47 electrically isolating it from the second conductor H which has its own layer of insulation 49.
  • FIG. 8 describes a schematic view of an implantable electrode of the present invention in use as a transvenous defibrillator lead with a human heart.

Abstract

An implantable electrode in the form a helically wound conductor having an electrically conductive polymeric layer coaxially surrounding and contacting the helically wound conductor, wherein the electrically conductive polymeric layer is electrically conductive in a dry state prior to implantation. Preferably, the electrode has two conductive portions, the additional second conductive portion being preferably located at the distal tip. The implantable electrode preferably incorporates an insulating portion wherein an additional length of the helically wound conductor is continuous with the remaining length of helically wound conductor coaxially covered by the electrically conductive polymeric layer. The insulating portion has a coaxial covering of impermeable polymeric electrically insulating material which is preferably silicone tubing. More preferably the coaxial covering of impermeably polymeric electrically insulating material has an additional exterior coaxial covering of porous PTFE for improved biocompatibility and flexibility. The porous PTFE is preferably porous expanded PTFE having a fibril length of less than 10 microns in order to substantially preclude tissue ingrowth and tissue attachment. The electrically conductive polymeric layer of the electrode is preferably made of porous expanded PTFE containing an electrically conductive filler, the porous expanded PTFE again having a fibril length of less than 10 microns.

Description

An Implantable Electrode
FIELD OF THE INVENTION
This invention relates to the field of implantable electrodes and in particular transvenous defibrillator leads and heart pacer sensing leads.
BACKGROUND OF THE INVENTION
Transvenous defibrillator leads are useful for the correction of ventricular tachycardia and ventricular fibrillation. Leads of this type are intravenously positioned so that the electrode portion of a lead is located within the right side of the heart. The lead may have only a single conductive electrode surface at or near the distal tip of the lead which is intended to be used in conjunction with an additional, separate and independent electrode such as a patch electrode located subcutaneously on the left side of the body.
Alternatively, the transvenous defibrillator lead may incorporate two separate electrodes at or near the distal tip of the lead which may be used in conjunction to deliver electrical energy to the heart. More than two electrodes may be provided within the distal tip portion if it is desired to provide electrodes for sensing as well as for delivering electrical energy.
Conventional transvenous defibrillator leads use a helically wound wire to conduct the electrical energy from the connector at the proximal end of the lead to the electrode at the distal end. Multiple conductor wires typically are in the form of separate helically wound wires in coaxial relationship wherein each wire is separated from an adjacent wire by a tubular insulating layer. Alternatively they may be in the form of a co-linear helical winding wherein the individual wires are individually insulated prior to winding into a single helical form.
The conductive electrode surface is most commonly provided by leaving a length of the helically wound wire uninsulated and exposed to allow it to be exposed to the interior surface of the heart. While using the helically wound wire has the advantage of eliminating a connection between a separate electrode and the conductor wire, it has a fundamental disadvantage in that tissue grows into the exposed helically wound wire over time with the result that the lead can be extremely difficult to remove by the application of tension to the proximal end of the lead.
Various methods have been attempted to overcome this difficulty. For example, U. S. Patent 5,090,422 describes the use of a porous covering for use over the electrode surface wherein the covering is made of a biocompatible material which may be an insulating material but becomes conductive by virtue of penetration of the material by conductive body fluids. The porous covering is of adequately small pore size to preclude substantial tissue ingrowth. Recommended materials include woven, porous polyurethane and porous polytetrafluoroethylene if used with a wetting agent or surface modifier.
SUMMARY OF THE INVENTION
The present invention is an implantable electrode which comprises a helically wound conductor having an electrically conductive polymeric layer coaxially surrounding and contacting the helically wound conductor, wherein the electrically conductive polymeric layer is electrically conductive in a dry state prior to implantation. The implantable electrode is primarily useful for transferring high levels of electrical energy for defibrillation to interior surfaces of a living heart, for example as the electrode portion of a transvenous defibrillator lead. Alternatively, the implantable electrode is also useful for transferring much lower levels of electrical energy, for example, sensing signal levels as required by pacing systems.
The implantable electrode is preferably connected to a source of electrical energy by an appropriate length of insulated wire. The helically wound conductor portion of the insulated wire is preferably continuous with the helically wound conductor that is coaxially covered by the electrically conductive polymeric layer and thereby forms the electrode surface that transfers energy to the heart. The helically wound conductor can therefore be said to have a first lengt portion that is coaxially covered by an electrically conductive polymeric layer, hereinafter termed the conductive portion, and a second length portion that is coaxially covered by an electrically insulating layer, hereinafter termed the insulating portion. The insulating layer coaxially covering the second length portion of the helically wound conductor is required to be made of an impermeable polymeric electrically insulating material such as silicone in order that the helically wound conductor is electrically isolated from contact with body fluids. Impermeable is used herein to describe a material that is substantially impervious to the transfer of ions across the thickness of the material. Preferably the insulating laye of impermeable polymeric electrically insulating material has an additional coaxial covering that provides the exterior surface of the insulated wire, the additional coaxial covering being porous polytetrafluoroethylene (hereinafter PTFE) of small pore size in orde to substantially preclude tissue ingrowth into the void spaces of the porous PTFE. The function of the porous PTFE exterior surface of the insulated wire is to provide better biocompatibility and flexibility than is possible with the impermeable polymeric electrically insulating material alone.
The electrically conductive polymeric layer which comprises the coaxial covering of the conductive portion and is intended as the surface material that transfers electrical energy to the heart, is preferably made of porous PTFE containing a carbon filler. This material is electrically conductive in a dry state prior to implantation and also offers good biocompatibility. The electrically conductive polymeric layer may be of tubular form or alternatively ma be in the form of a tape that is helically wrapped about the surface of the first length portion of the helically wound conductor.
The helically wound conductors are preferably MP35N stainless steel-nickel alloy and most preferably are wound from a wire made as drawn, filled tube in the form of a silver core having an exterior surface coating of MP35N alloy. This type of conductor offers very good conductivity without exposing the silver conductor core to possible undesirable biological contact. The implantable electrode of the present invention may be made with more than two electrodes by locating the electrodes sequentially along the length of the distal end of the implantable electrode. The electrodes are separated axially by lengths of insulating material such as silicone. The individual electrodes are supplied with electrical energy by individual helical wound conductors insulated from each other in either coaxial or co-linear relationship. The term co-linear describes a relationship wherein two or more individually insulated conductors are wound parallel to each other within the same helix.
Conventional connectors may be used to terminate the proximal end of the insulating portion for connection to a defibrillator energy source.
The porous PTFE used in various portions of the construction of the inventive implantable electrode is preferably porous expanded PTFE which for the purpose of this invention is herein defined as porous PTFE having a microstructure of nodes interconnected by fibrils. Porous expanded PTFE is described by and made according to the teachings of U. S. Patents 4,187,390 and 3,953,556. The porous PTFE containing a carbon filler used for the surface of the conductive portion of the electrode is preferably porous expanded PTFE made according to the teachings of U. S. Patents 4,096,227; 4,187,390; 4,985,296 and 5,148,806.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 describes a perspective view of an implantable electrode of the present invention incorporating a single conductive portion. Figures 2 and 2A describe alternative cross sections of the implantable electrode of Figure 1. Figure 3 describes a perspective view of a preferred embodiment of the implantable electrode incorporating two conductive portions. Figure 4 describes a cross section of the implantable electrode of
Figure 3. Figure 4A describes an alternative embodiment to the implantable electrode shown by Figure 4 wherein the insulating portion has an exterior layer of porous polymeric material with an underlying layer of impermeable polymeric insulating material.
Figure 5 describes a cross section of an alternative to the embodiment of Figures 3 and 4 incorporating a different tip construction. Figure 6 describes a cross section of an alternative to the embodiment of Figure 3 wherein the porous PTFE insulating material and the porous PTFE conductive material are secured to the surface of the helically wound conductor by a layer of a adhesive.
Figure 7 describes a cross section of an alternative to the embodiment of Figure 3 wherein the two helically wound conductors within the insulating portion are in co-linear relationship.
Figure 8 is a schematic view of the implantable electrode of the present invention in use with a human heart.
DETAILED DESCRIPTION OF THE INVENTION
Figure 1 shows the implantable electrode 1Q of the present invention having an insulating portion 21. a conductive portion 21 and a conventional connector H terminating the proximal end of the electrode JO. As shown by the cross sectional view of Figure 2, electrical energy is supplied to the conductive portion 13 by a helically wound conductor 3L The insulating material 13 coaxially covering the insulating portion 21 is comprised of a layer of impermeable polymeric electrically insulating material such as silicone tubing. The conductive portion 22 is comprised of an electrically conductive polymeric layer 15 which is electrically conductive in a dry state prior to implantation. The electrically conductive polymeric layer 15 is in direct electrical contact with the helically wound conductor 31 that supplies electrical energy to the conductive portion 23. This electrically conductive polymeric layer 15 is preferably comprised of a helically wrapped, porous PTFE tape containing a carbon filler wherein adjacent edges of the tape are overlapping. The porous PTFE containing a carbon filler is required to be of small pore size such as less than about 10 microns in order to limit tissue ingrowth. The distal end of this embodiment is covered by a cap 16 of either electrically conductive or electrically insulating material intended to close off the end of the tubular construction of the electrode J_0.
The use of an electrically conductive polymeric material as the tissue contacting portion of the electrode is a significant improvement over conventional transvenous defibrillator leads relying on direct contact between an exposed portion of a helically wound conductor and living tissue. The difficulty with these conventional transvenous defibrillator leads is that over time tissue grows into the exposed portion of the helically wound conductor with the result that it becomes very difficult to withdraw the lead by applying traction to the proximal end. The conductive portion 2 of the present invention is either non-porous or alternatively of a porous material having a pore size adequately small to substantially preclude tissue ingrowth. Adequately small pore sizes are typically of 10 micron diameter or smaller. Porous PTFE and particularly porous expanded PTFE are preferred materials for the exterior surfaces of both the insulating portion 21 and conductive portion 22 because the porous PTFE is a chemically inert material with a long history of use in implantable medical devices and is well known to produce very little adverse tissue reaction. Additionally, the porous nature of the material allows the implantable electrode to be highly flexible and kink resistant.
The conductive porous PTFE for use as the electrically conductive polymeric layer that comprised the surface of the conductive portion 2 may be manufactured by uniformly distributing an electrically conductive filler throughout the porous PTFE during the process of making the porous PTFE layer. For example, if porous expanded PTFE is used, the electrically conductive particulate may be blended with the powdered PTFE resin prior to extrusion and expansion. Pore size of porous expanded PTFE is generally described as a function of the fibril length of the material. The fibril length of porous expanded PTFE is measured as taught by U. S. Patent 4,972,846 except that a sample magnification level greater than 100X may be necessary. Figure 2A describes an alternative embodiment wherein an additional relatively short length of a helically wound conductor 32 is fitted coaxially over the distal end of the first helically wound conductor 31 for the length of the conductive portion 23. At least a portion of the additional relatively short length of helically wound conductor 32 is in direct electrical contact with the first helically wound conductor 3_1. The use of the additional relatively short length of helically wound conductor 3_2 allows for a more corrosion resistant metal surface to which the electrically conductive polymer coaxial covering may be fitted. A preferred metal for the additional relatively short length of helically wound conductor 32 is titanium. Figure 3 shows a perspective view of a preferred embodiment of the implantable electrode of the present invention incorporating two conductive portions 2 and 19. Figure 4 describes a cross section of this embodiment. The first conductive portion 21 is comprised as described previously of a layer J_5 of electrically conductive polymeric material in contact with the first helically wound conductor 11. The second conductive portion 1_9 is located at the distal tip of the implantable electrode 10 and is preferably comprised of conventional metallic electrode materials such as platinum, carbon or titanium and may optionally incorporate a means for passively or positively attaching to a tissue surface, such as a barb, tine or screw thread. The second conductive portion 19 is connected to a second helically wound conductor H which is located coaxially within the lumen of the first helically wound conductor 3! and separated from the first helically wound conductor H by an impermeable tubular electrically insulating layer 22 which is preferably silicone tubing. The first and second conductive portions 23 and 19 are separated axially by a segment of impermeable polymeric electrically insulating material J_7 at the surface of the distal end of the electrode 10.
Figure 4A describes a cross section of an alternative embodiment to that described previously by Figure 4. The insulating layer of Figure 4A is comprised of separate inner and outer layers. Outer layer 41 is a coaxial covering of porous PTFE which is preferably porous expanded PTFE. The inner layer 41 is an impermeable polymeric electrically insulating layer. The use of porous PTFE for the exterior surface of the insulating portion 21 requires the use of an underlying impermeable polymeric electrically insulating layer 41.
This is because body fluids will wet through the porous PTFE exterior coaxial covering thereby negating its electrical insulating value. This is true even for small pore size insulating materials, for example, porous expanded PTFE of less than 10 micron fibril length. The impermeable polymeric electrically insulating layer may be any suitable material and may also serve as an adhesive to secure the exterior porous insulating material to the underlying electrical conductor. Suitable materials include silicone tubing, silicone adhesive, and fluoropolymer tubing or tapes that may be helically wrapped about the surface of the electrical conductor.
Figure 5 describes an alternative embodiment to those described previously by Figure 3 and Figure 4 wherein only the impermeable insulating tubular layer 21 separates the two electrodes at the surface of the implantable electrode 1_0. The additional layer of porous PTFE insulating material J_7 described previously in the embodiment of Figure 4 is omitted in this instance. Figure 6 shows a section of an alternative embodiment of the type described previously in Figures 3 and 4 wherein the porous PTFE . insulating material 41 comprising the surface of the insulating portion 21 of the implantable electrode 10 is secured to the helically wound conductor 31 by a layer of adhesive 41 which may optionally serve as the impermeable electrically insulating layer if the adhesive characteristics meet those requirements. The adhesive is preferably a thermoplastic adhesive which is preferably a fluoropolymer and most preferably FEP. The adhesive securing the porous PTFE insulating material 41 may be either continuous as shown by layer 4_l or alternatively may be discontinuous. If the adhesive layer is discontinuous, the use of a separate impermeable electrically insulating layer will be required. The electrically conductive polymeric material J> may also be secured by a layer of adhesive 46 which should be discontinuous in order to allow for good electrical contact with the helically wound conductor 3J,. Alternatively the layer of adhesive 46 may be an electrically conductive adhesive and therefore may be applied continuously.
One such non-conductive adhesive is a dispersion of water, fluorinated ethylene propylene (hereinafter FEP) in the form of a particulate and a surfactant, available from DuPont (Wilmington, DE) under the product name Teflon® FEP 120 Aqueous Dispersion. It has surprisingly been found that a thin layer of non-conductive polymeric adhesive produces good adhesion with little additional electrical resistance. Alternatively, conductive fillers such as carbon black may be added to this dispersion in order to make it electrically conductive. Six percent acetylene black (Shawinigan Acetylene Black, Gulf Canada Ltd., Montreal, Quebec, Canada) by weight of FEP has been found adequate to provide the adhesive with suitable electrical conductivity. This dispersion with and without acetylene black has been found useful to adhere the electrically conductive polymeric material of the electrode surface to the underlying helically wound conductor.
In another alternative, the porous PTFE may be made in sheet form having a layer of either continuous or discontinuous thermoplastic adhesive applied to one side of the porous PTFE sheet. After application of the adhesive to the PTFE sheet as will be described, the composite may then be slit into relatively narrow lengths of tape for subsequent helical wrapping about the conductor wire surface with the adhesive side of the composite contacting the conductor and the porous PTFE side facing outwardly. The helically wrapped conductor may then be heated to a temperature above the melt point of the thermoplastic adhesive to cause effective bonding of the composite tape to the conductor surface.
The process of making the porous PTFE material having a layer of either continuous or discontinuous thermoplastic adhesive comprises: a) contacting a porous PTFE substrate, usually in the form of a membrane of film, with a layer, usually a film of a thermoplastic polymer; b) heating the composition obtained in step a) to a temperature above the melting point of the thermoplastic polymer; c) stretching the heated composition of step b) while maintaining the temperature above the melting point of the thermoplastic polymer; and d) cooling the product of step c).
Depending on the degree of stretching, the thermoplastic film can form a very thin, i.e., 9 micron or less thick, film on the surface o the expanded porous PTFE which is continuous and non-porous. Or, if the degree of stretching is great enough, the thermoplastic film will eventually rend and form rents. The rents are usually slit-like openings if the thermoplastic film is initially relatively thick, or are usually wider gaps or holes if the thermoplastic film is initially relatively thin. Such a film having gaps or holes is herein considered to be discontinuous. The thermoplastic film is preferably a fluoropolymer and most preferably FEP. The completed film may be slit into lengths of narrow tape for subsequent helical wrapping about the surface of an electrical conductor.
While Figure 6 describes the porous PTFE insulating material 41 as being in the form of a continuous tube and the electrically conductive polymeric material Jj> as being in the form of a helically wrapped tape, it is apparent that either continuous tubes or helically wrapped tapes may be used to provide the surface material for either the insulative portion 21 or the electrically conductive portion 21- Both the continuous tube covering and the helically wrapped covering may be secured as described by the thermoplastic adhesive.
Figure 7 describes a cross section of an alternative to the embodiment of Figure 3 wherein the first 11 and second H helically wound conductors within the insulating portion are in co-linear relationship wherein the two insulated conductors are wound parallel to each other within the same helix. The first H and second H helically wound conductors are separately insulated wherein the first conductor H has a layer of insulation 47 electrically isolating it from the second conductor H which has its own layer of insulation 49. At the beginning of the electrically conductive portion 21* the first and second H helically wound conductors are separated into a coaxial relationship wherein the layer of insulation 47 has been removed from the first helically wound conductor H, thereby allowing conductor 3_i to be in direct electrical contact with conductive portion 21- The first U and second H helically wound conductors are insulated from each other beginning from the proximal end of the conductive portion 21 by a layer of impermeable polymeric electrically insulating material 4j> coaxially covering the second helically wound conductor H which is in turn electrically connected to a distal tip electrode 19. Figure 8 describes a schematic view of an implantable electrode of the present invention in use as a transvenous defibrillator lead with a human heart.

Claims

We Claim:
1. An implantable electrode comprising at least one helically wound conductor having a first length portion wherein a layer of electrically conductive polymeric material coaxially surrounds and contacts the first length portion of the at least one helically wound conductor, and wherein the layer of electrically conductive polymeric material is electrically conductive in a dr state prior to implantation.
2. An implantable electrode according to claim 1 wherein the electrically conductive polymer is porous polytetrafluoroethylen containing an electrically conductive filler.
3. An implantable electrode according to claim 2 wherein the porous polytetrafluoroethylene containing an electrically conductive filler is in the form of a helically wrapped tape.
4. An implantable electrode according to claim 3 wherein the electrically conductive filler is a carbon filler.
5. An implantable electrode according to claim 2 wherein the porous polytetrafluoroethylene containing an electrically conductive filler is secured to the first length portion of the helically wound conductor by a discontinuous thermoplastic adhesive.
6. An implantable electrode according to claim 5 wherein the discontinuous thermoplastic adhesive is a fluoropolymer.
7. An implantable electrode according to claim 6 wherein the fluoropolymer is fluorinated ethylene propylene.
8. An implantable electrode according to claim 2 wherein the porous polytetrafluoroethylene containing an electrically conductive filler is secured to the first length portion of the helically wound conductor by an electrically conductive adhesive.
9. An implantable electrode according to claim 2 wherein the porous polytetrafluoroethylene is porous expanded polytetrafluoro¬ ethylene.
10. An implantable electrode according to claim 9 wherein the porous expanded polytetrafluoroethylene has a mean fibril length of les than about 10 microns.
11. An implantable electrode according to claim 10 wherein the porou expanded polytetrafluoroethylene is in the form of a helically wrapped tape.
12. An implantable electrode according to claim 11 wherein the electrically conductive filler is a carbon filler.
13. An implantable electrode according to claim 1 wherein the at least one helically wound conductor has a second length portion continuously and electrically connected to the first length portion, and further has an insulating portion wherein the second length portion of the at least one helically wound conductor has a layer of impermeable polymeric electrically insulating material coaxially covering the second length portion of the at least one helically wound conductor.
14. An implantable electrode according to claim 13 wherein the electrically conductive polymer is porous polytetrafluoroethylene containing an electrically conductive filler.
15. An implantable electrode according to claim 14 wherein the porous polytetrafluoroethylene containing an electrically conductive filler is in the form of a helically wrapped tape.
16. An implantable electrode according to claim 15 wherein the electrically conductive filler is a carbon filler.
17. An implantable electrode according to claim 14 wherein the porous polytetrafluoroethylene containing an electrically conductive filler is secured to the first length portion of the helically wound conductor by a discontinuous thermoplastic adhesive.
18. An implantable electrode according to claim 17 wherein the discontinuous thermoplastic adhesive is a fluoropolymer.
19. An implantable electrode according to claim 18 wherein the fluoropolymer is fluorinated ethylene propylene.
20. An implantable electrode according to claim 14 wherein the porous polytetrafluoroethylene containing an electrically conductive filler is secured to the first length portion of the helically wound conductor by an electrically conductive adhesive.
21. An implantable electrode according to claim 14 wherein the porous polytetrafluoroethylene is porous expanded polytetrafluoro¬ ethylene.
22. An implantable electrode according to claim 21 wherein the porous expanded polytetrafluoroethylene has a mean fibril length of less than about 10 microns.
23. An implantable electrode according to claim 22 wherein the porous expanded polytetrafluoroethylene is in the form of a helically wrapped tape.
24. An implantable electrode according to claim 23 wherein the electrically conductive filler is a carbon filler.
25. An implantable electrode according to claim 13 wherein the impermeable polymeric electrically insulating material is silicone.
26. An implantable electrode according to claim 13 wherein the impermeable polymeric electrically insulating material has an exterior coaxial covering of porous polytetrafluoroethylene.
27. An implantable electrode according to claim 25 wherein the silicone has an exterior coaxial covering of porous polytetrafluoroethylene.
28. An implantable electrode according to claim 26 wherein the porous polytetrafluoroethylene is porous expanded polytetraf1uoroethylene.
29. An implantable electrode according to claim 28 wherein the porous expanded polytetrafluoroethylene has a mean fibril length less than about 10 microns.
30. An implantable electrode according to claim 24 wherein the impermeable polymeric electrically insulating material is silicone.
31. An implantable electrode according to claim 30 wherein the impermeable polymeric electrically insulating material has an exterior coaxial covering of porous polytetrafluoroethylene.
32. An implantable electrode according to claim 31 wherein the porous polytetrafluoroethylene is porous expanded polytetraf1uoroethylene.
33. An implantable electrode according to claim 32 wherein the porou expanded polytetrafluoroethylene has a mean fibril length less than about 10 microns.
34. An implantable electrode according to claim 1 wherein an additional relatively short length of a helically wound conductor coaxially covers and contacts a portion of the at least one helically wound conductor and is disposed between the at least one helically wound conductor and the layer of electrically conductive polymeric material.
35. An implantable electrode according to claim 12 wherein an additional relatively short length of a helically wound conductor coaxially covers and contacts a portion of the at least one helically wound conductor and is disposed between the at least one helically wound conductor and the layer of electrically conductive polymeric material.
36. An implantable electrode according to claim 13 wherein an additional relatively short length of a helically wound conductor coaxially covers and contacts a portion of the at least one helically wound conductor and is disposed between the at least one helically wound conductor and the layer of electrically conductive polymeric material.
37. An implantable electrode according to claim 13 wherein an additional helically wound conductor is coaxially disposed within the at least one helically wound conductor and electrically insulated from the at least one helically wound conductor by a layer of impermeable polymeric electrically insulating material coaxially disposed between the additional helically wound conductor and the at least one helically wound conductor, wherein the additional helically wound conductor is electrically connected to an electrically conductive component intended to transfer electrical energy to a tissue surface, the electrically conductive component being electrically insulated from the layer of electrically conductive polymeric material.
38. An implantable electrode according to claim 13 wherein an additional helically wound conductor is co-linearly disposed with the at least one helically wound conductor and electrically insulated from the at least one helically wound conductor by a layer of impermeable polymeric electrically insulating material coaxially covering the additional helically wound conductor and a second layer of impermeable polymeric electrically insulating material coaxially covering the at least one helically wound conductor, wherein the additional helically wound conductor is electrically connected to an electrically conductive component intended to transfer electrical energy to a tissue surface, the electrically conductive component being electrically insulated from the layer of electrically conductive polymeric material.
PCT/US1993/005777 1993-02-01 1993-06-16 An implantable electrode WO1994017852A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002152604A CA2152604C (en) 1993-02-01 1993-06-16 An implantable electrode
JP6504456A JPH08505539A (en) 1993-02-01 1993-06-16 Electrode for implant
DE69326080T DE69326080T2 (en) 1993-02-01 1993-06-16 IMPLANTABLE ELECTRODE
EP93916575A EP0681494B1 (en) 1993-02-01 1993-06-16 An implantable electrode

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1488293A 1993-02-01 1993-02-01
US08/014,882 1993-02-01

Publications (1)

Publication Number Publication Date
WO1994017852A1 true WO1994017852A1 (en) 1994-08-18

Family

ID=21768325

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1993/005777 WO1994017852A1 (en) 1993-02-01 1993-06-16 An implantable electrode

Country Status (6)

Country Link
US (1) US5609622A (en)
EP (1) EP0681494B1 (en)
JP (1) JPH08505539A (en)
CA (1) CA2152604C (en)
DE (1) DE69326080T2 (en)
WO (1) WO1994017852A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571159A (en) * 1994-04-04 1996-11-05 Alt; Eckhard Temporary atrial defibrillation catheter and method
US5861023A (en) * 1997-12-16 1999-01-19 Pacesetter, Inc. Thrombus and tissue ingrowth inhibiting overlays for defibrillator shocking coil electrodes
WO2002032497A1 (en) * 2000-10-20 2002-04-25 Advanced Metal Coatings Pty Limited An electrical lead
EP2158936A3 (en) * 2008-07-05 2011-02-16 Peter Osypka Medicinal catheter with several poles or electrodes
US8286338B2 (en) 2004-08-05 2012-10-16 Cathrx Ltd Process of manufacturing a medical use electrical lead
US8649878B2 (en) 2009-06-19 2014-02-11 Greatbatch Ltd. Temporary stimulation lead with polymer electrodes and method of manufacture
US8903511B2 (en) 2005-06-10 2014-12-02 Cardiac Pacemakers Inc. Lead assembly with porous polyethylene cover
EP3181188A1 (en) * 2015-12-15 2017-06-21 BIOTRONIK SE & Co. KG Extendable eclectrode

Families Citing this family (106)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603318D0 (en) * 1996-09-12 1996-09-12 Pacesetter Ab Electrode cable for electrical stimulation
US5782898A (en) * 1996-10-15 1998-07-21 Angeion Corporation System for anchoring mid-lead electrode on an endocardial catheter lead
US5755766A (en) * 1997-01-24 1998-05-26 Cardiac Pacemakers, Inc. Open-ended intravenous cardiac lead
SE9701719D0 (en) * 1997-05-07 1997-05-07 Pacesetter Ab Helical winding
US5931862A (en) * 1997-12-22 1999-08-03 Pacesetter, Inc. Medical lead and method of making and using with sodium sulfosuccinic ester
WO1999064100A1 (en) 1998-06-12 1999-12-16 Cardiac Pacemakers, Inc. Modified guidewire for left ventricular access lead
US6240321B1 (en) 1998-08-12 2001-05-29 Cardiac Pacemakers, Inc. Expandable seal for use with medical device and system
US6634364B2 (en) 2000-12-15 2003-10-21 Cardiac Pacemakers, Inc. Method of deploying a ventricular lead containing a hemostasis mechanism
US6546292B1 (en) 1998-11-04 2003-04-08 Gore Enterprise Holdings, Inc. High impedance, low polarization cardiac electrode
US7047082B1 (en) * 1999-09-16 2006-05-16 Micronet Medical, Inc. Neurostimulating lead
US7013182B1 (en) 2000-05-04 2006-03-14 Cardiac Pacemakers, Inc. Conductive polymer sheath on defibrillator shocking coils
US6456890B2 (en) 2000-05-15 2002-09-24 Pacesetter, Inc. Lead with polymeric tubular liner for guidewire and stylet insertion
US6456889B2 (en) 2000-05-15 2002-09-24 Pacesetter, Inc. Lead with polymeric tubular liner for guidewire and stylet insertion
US6408199B1 (en) 2000-07-07 2002-06-18 Biosense, Inc. Bipolar mapping of intracardiac potentials with electrode having blood permeable covering
US6456888B1 (en) 2000-08-18 2002-09-24 Cardiac Pacemakers, Inc. Geometry for coupling and electrode to a conductor
US7555349B2 (en) * 2000-09-26 2009-06-30 Advanced Neuromodulation Systems, Inc. Lead body and method of lead body construction
US6952616B2 (en) * 2000-09-26 2005-10-04 Micronet Medical, Inc. Medical lead and method for electrode attachment
US7039470B1 (en) 2000-09-26 2006-05-02 Micronet Medical, Inc. Medical lead and method for medical lead manufacture
US6704604B2 (en) * 2000-12-28 2004-03-09 Medtronic, Inc. System and method for promoting selective tissue in-growth for an implantable medical device
US6571125B2 (en) 2001-02-12 2003-05-27 Medtronic, Inc. Drug delivery device
US6952809B2 (en) * 2001-03-30 2005-10-04 International Business Machines Corporation Method and apparatus for navigating a windowed operating environment
WO2002085425A1 (en) 2001-04-20 2002-10-31 Medtronic, Inc. Enhanced chronic lead removal
US7020529B2 (en) 2001-05-02 2006-03-28 Gore Enterprise Holdings, Inc. Defibrillation electrode cover
US6999821B2 (en) * 2002-01-18 2006-02-14 Pacesetter, Inc. Body implantable lead including one or more conductive polymer electrodes and methods for fabricating same
US7231259B2 (en) * 2002-10-04 2007-06-12 Pacesetter, Inc. Body implantable lead comprising electrically conductive polymer conductors
US7844347B2 (en) * 2002-12-06 2010-11-30 Medtronic, Inc. Medical devices incorporating carbon nanotube material and methods of fabricating same
US20050060004A1 (en) * 2003-09-12 2005-03-17 Cooke Daniel J. Expanded ultra-high molecular weight polyethylene in an electrical medical device
US20050080470A1 (en) * 2003-10-09 2005-04-14 Randy Westlund Intramyocardial lead implantation system and method
US7197362B2 (en) * 2003-12-11 2007-03-27 Cardiac Pacemakers, Inc. Cardiac lead having coated fixation arrangement
US7844344B2 (en) * 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable lead
US8989840B2 (en) 2004-03-30 2015-03-24 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7844343B2 (en) * 2004-03-30 2010-11-30 Medtronic, Inc. MRI-safe implantable medical device
US9155877B2 (en) * 2004-03-30 2015-10-13 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7877150B2 (en) * 2004-03-30 2011-01-25 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US20050228469A1 (en) * 2004-04-12 2005-10-13 Cardiac Pacemakers, Inc. Electrode and conductor interconnect and method therefor
SE528688C2 (en) * 2004-05-17 2007-01-23 Anders Carlsson Device for measuring temperature and heat content over a surface
US7561915B1 (en) 2004-12-17 2009-07-14 Cardiac Pacemakers, Inc. MRI system having implantable device safety features
US8014867B2 (en) * 2004-12-17 2011-09-06 Cardiac Pacemakers, Inc. MRI operation modes for implantable medical devices
US8280526B2 (en) * 2005-02-01 2012-10-02 Medtronic, Inc. Extensible implantable medical lead
US8027736B2 (en) * 2005-04-29 2011-09-27 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US7853332B2 (en) 2005-04-29 2010-12-14 Medtronic, Inc. Lead electrode for use in an MRI-safe implantable medical device
US9295833B2 (en) * 2005-05-31 2016-03-29 St. Jude Medical, AB Implantable medical lead
US7749265B2 (en) * 2005-10-05 2010-07-06 Kenergy, Inc. Radio frequency antenna for a wireless intravascular medical device
US8535704B2 (en) * 2005-12-29 2013-09-17 Medtronic, Inc. Self-assembling cross-linking molecular nano film
US20070225610A1 (en) * 2006-03-27 2007-09-27 Boston Scientific Scimed, Inc. Capturing electrical signals with a catheter needle
US7881808B2 (en) * 2006-03-29 2011-02-01 Cardiac Pacemakers, Inc. Conductive polymeric coating with optional biobeneficial topcoat for a medical lead
US7610101B2 (en) 2006-11-30 2009-10-27 Cardiac Pacemakers, Inc. RF rejecting lead
US20080183261A1 (en) * 2007-01-31 2008-07-31 Cardiac Pacemakers, Inc. Fibrosis-limiting material attachment
US9044593B2 (en) * 2007-02-14 2015-06-02 Medtronic, Inc. Discontinuous conductive filler polymer-matrix composites for electromagnetic shielding
US10537730B2 (en) * 2007-02-14 2020-01-21 Medtronic, Inc. Continuous conductive materials for electromagnetic shielding
US8483842B2 (en) 2007-04-25 2013-07-09 Medtronic, Inc. Lead or lead extension having a conductive body and conductive body contact
US20090076580A1 (en) * 2007-09-13 2009-03-19 Medtronic, Inc. Medical electrical lead
US8086321B2 (en) 2007-12-06 2011-12-27 Cardiac Pacemakers, Inc. Selectively connecting the tip electrode during therapy for MRI shielding
WO2009076163A2 (en) * 2007-12-06 2009-06-18 Cardiac Pacemakers, Inc. Implantable lead having a variable coil conductor pitch
US8032228B2 (en) 2007-12-06 2011-10-04 Cardiac Pacemakers, Inc. Method and apparatus for disconnecting the tip electrode during MRI
AU2009212697B2 (en) 2008-02-06 2011-12-01 Cardiac Pacemakers, Inc. Lead with MRI compatible design features
US8311637B2 (en) 2008-02-11 2012-11-13 Cardiac Pacemakers, Inc. Magnetic core flux canceling of ferrites in MRI
US8160717B2 (en) 2008-02-19 2012-04-17 Cardiac Pacemakers, Inc. Model reference identification and cancellation of magnetically-induced voltages in a gradient magnetic field
US9037263B2 (en) 2008-03-12 2015-05-19 Medtronic, Inc. System and method for implantable medical device lead shielding
US20090319014A1 (en) * 2008-05-07 2009-12-24 David Muecke Lead assembly and related methods
US20090287285A1 (en) * 2008-05-07 2009-11-19 Lynn Mark C Lead assembly and related methods
US8639356B2 (en) * 2008-05-07 2014-01-28 Cardiac Pacemakers, Inc. Lead assembly and related methods
US9265936B2 (en) 2008-05-07 2016-02-23 Cardiac Pacemakers, Inc. Lead assembly and related methods
US8401669B2 (en) * 2008-05-07 2013-03-19 Cardiac Pacemakers, Inc. Lead assembly and related methods
US8103360B2 (en) 2008-05-09 2012-01-24 Foster Arthur J Medical lead coil conductor with spacer element
US8571661B2 (en) 2008-10-02 2013-10-29 Cardiac Pacemakers, Inc. Implantable medical device responsive to MRI induced capture threshold changes
US8996134B2 (en) 2008-11-07 2015-03-31 W. L. Gore & Associates, Inc. Implantable lead
US8364281B2 (en) * 2008-11-07 2013-01-29 W. L. Gore & Associates, Inc. Implantable lead
WO2010056446A1 (en) * 2008-11-14 2010-05-20 Cardiac Pacemakers, Inc. Eptfe fill of coil filar gaps
EP2385960B1 (en) * 2009-01-12 2020-03-11 University Of Massachusetts Lowell Polyisobutylene-based polyurethanes
US8639331B2 (en) * 2009-02-19 2014-01-28 Cardiac Pacemakers, Inc. Systems and methods for providing arrhythmia therapy in MRI environments
US10045868B2 (en) * 2009-03-04 2018-08-14 W. L. Gore & Associates Inc. Atraumatic vascular graft removal sheath
US8326437B2 (en) 2009-03-04 2012-12-04 W. L. Gore & Associates, Inc. Atraumatic lead removal sheath
US9084883B2 (en) 2009-03-12 2015-07-21 Cardiac Pacemakers, Inc. Thin profile conductor assembly for medical device leads
US9186499B2 (en) 2009-04-30 2015-11-17 Medtronic, Inc. Grounding of a shield within an implantable medical lead
WO2010151376A1 (en) 2009-06-26 2010-12-29 Cardiac Pacemakers, Inc. Medical device lead including a unifilar coil with improved torque transmission capacity and reduced mri heating
AU2010284137B2 (en) 2009-08-21 2014-11-27 Cardiac Pacemakers, Inc. Crosslinkable polyisobutylene-based polymers and medical devices containing the same
US8374704B2 (en) 2009-09-02 2013-02-12 Cardiac Pacemakers, Inc. Polyisobutylene urethane, urea and urethane/urea copolymers and medical leads containing the same
US8644952B2 (en) 2009-09-02 2014-02-04 Cardiac Pacemakers, Inc. Medical devices including polyisobutylene based polymers and derivatives thereof
WO2011049684A1 (en) * 2009-10-19 2011-04-28 Cardiac Pacemakers, Inc. Mri compatible tachycardia lead
EP2509682B1 (en) 2009-12-08 2015-01-14 Cardiac Pacemakers, Inc. Implantable medical device with automatic tachycardia detection and control in mri environments
EP2519311A1 (en) * 2009-12-30 2012-11-07 Cardiac Pacemakers, Inc. Mri-conditionally safe medical device lead
US8391994B2 (en) 2009-12-31 2013-03-05 Cardiac Pacemakers, Inc. MRI conditionally safe lead with low-profile multi-layer conductor for longitudinal expansion
CN102655908B (en) 2009-12-31 2015-04-22 心脏起搏器公司 MRI conditionally safe lead with multi-layer conductor
US8825181B2 (en) 2010-08-30 2014-09-02 Cardiac Pacemakers, Inc. Lead conductor with pitch and torque control for MRI conditionally safe use
AU2011329442B2 (en) * 2010-11-18 2014-07-03 Cardiac Pacemakers, Inc. Insulative structure for MRI compatible leads
US8666512B2 (en) 2011-11-04 2014-03-04 Cardiac Pacemakers, Inc. Implantable medical device lead including inner coil reverse-wound relative to shocking coil
WO2013158189A1 (en) 2012-04-19 2013-10-24 Medtronic, Inc. Paired medical lead bodies with braided conductive shields having different physical parameter values
US8825179B2 (en) 2012-04-20 2014-09-02 Cardiac Pacemakers, Inc. Implantable medical device lead including a unifilar coiled cable
US8954168B2 (en) 2012-06-01 2015-02-10 Cardiac Pacemakers, Inc. Implantable device lead including a distal electrode assembly with a coiled component
JP6069499B2 (en) 2012-08-31 2017-02-01 カーディアック ペースメイカーズ, インコーポレイテッド Lead wire with low peak MRI heating
NO334551B1 (en) * 2012-08-31 2014-04-07 Nexans Cable electrode system for a device for reducing unwanted organisms in a fish and / or shellfish aquaculture facility
JP6034499B2 (en) 2012-10-18 2016-11-30 カーディアック ペースメイカーズ, インコーポレイテッド Inductive element for providing MRI compatibility in implantable medical device leads
US9926399B2 (en) 2012-11-21 2018-03-27 University Of Massachusetts High strength polyisobutylene polyurethanes
EP2853288B1 (en) * 2013-08-26 2019-10-30 BIOTRONIK SE & Co. KG Implantable device and production method for an implantable device
US9370653B2 (en) * 2013-12-05 2016-06-21 Advanced Neuromodulation Systems, Inc. Medical leads with segmented electrodes and methods of fabrication thereof
US9993638B2 (en) 2013-12-14 2018-06-12 Medtronic, Inc. Devices, systems and methods to reduce coupling of a shield and a conductor within an implantable medical lead
EP3110499B1 (en) 2014-02-26 2018-01-24 Cardiac Pacemakers, Inc. Construction of an mri-safe tachycardia lead
WO2016014427A1 (en) 2014-07-23 2016-01-28 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions
US10155111B2 (en) 2014-07-24 2018-12-18 Medtronic, Inc. Methods of shielding implantable medical leads and implantable medical lead extensions
JP2019508218A (en) 2016-03-18 2019-03-28 テレフレックス イノベーションズ エス.アー.エール.エル. Pacing guidewire
WO2018165273A1 (en) 2017-03-07 2018-09-13 Cardiac Pacemakers, Inc. Hydroboration/oxidation of allyl-terminated polyisobutylene
CN110997746B (en) 2017-08-17 2021-12-28 心脏起搏器股份公司 Photocrosslinked polymers for enhanced durability
EP3740253B1 (en) 2018-01-17 2023-08-16 Cardiac Pacemakers, Inc. End-capped polyisobutylene polyurethane
US11684702B2 (en) * 2019-05-24 2023-06-27 Conmed Corporation Gap control in electrosurgical instruments using expanded polytetrafluoroethylene
EP3858424A1 (en) * 2020-01-29 2021-08-04 BIOTRONIK SE & Co. KG Tube assembly and medical product comprising such a tube assembly

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3305271A1 (en) * 1983-02-16 1984-08-16 Siemens AG, 1000 Berlin und 8000 München ELECTRODE ARRANGEMENT
CH656313A5 (en) * 1982-05-24 1986-06-30 Straumann Inst Ag Electrode with an electrical conductor which is connected to a contact provided for forming a connection with tissue
US5016646A (en) * 1988-11-29 1991-05-21 Telectronics, N.V. Thin electrode lead and connections
US5090422A (en) * 1990-04-19 1992-02-25 Cardiac Pacemakers, Inc. Implantable electrode pouch
US5148806A (en) * 1988-12-23 1992-09-22 Yasuhiro Fukui Electrode for use with a living body

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE392582B (en) * 1970-05-21 1977-04-04 Gore & Ass PROCEDURE FOR THE PREPARATION OF A POROST MATERIAL, BY EXPANDING AND STRETCHING A TETRAFLUORETENE POLYMER PREPARED IN AN PASTE-FORMING EXTENSION PROCEDURE
US4096227A (en) * 1973-07-03 1978-06-20 W. L. Gore & Associates, Inc. Process for producing filled porous PTFE products
US4030509A (en) * 1975-09-30 1977-06-21 Mieczyslaw Mirowski Implantable electrodes for accomplishing ventricular defibrillation and pacing and method of electrode implantation and utilization
US4033355A (en) * 1975-11-28 1977-07-05 Cardiac Pacemakers, Inc. Electrode lead assembly for implantable devices and method of preparing same
US4291707A (en) * 1979-04-30 1981-09-29 Mieczyslaw Mirowski Implantable cardiac defibrillating electrode
US4280511A (en) * 1980-02-25 1981-07-28 Medtronic, Inc. Ring electrode for pacing lead and process of making same
US4328812A (en) * 1980-03-21 1982-05-11 Medtronic, Inc. Ring electrode for pacing lead
US4481953A (en) * 1981-11-12 1984-11-13 Cordis Corporation Endocardial lead having helically wound ribbon electrode
JPS598937A (en) * 1982-07-08 1984-01-18 塩野義製薬株式会社 Minute electrode and production thereof
US4458695A (en) * 1982-07-16 1984-07-10 Cordis Corporation Multipolar electrode assembly for pacing lead
US4499907A (en) * 1982-11-15 1985-02-19 Medtronic, Inc. Energy limiting cardioversion lead
US4559951A (en) * 1982-11-29 1985-12-24 Cardiac Pacemakers, Inc. Catheter assembly
US4542752A (en) * 1983-04-22 1985-09-24 Cordis Corporation Implantable device having porous surface with carbon coating
US4641656A (en) * 1985-06-20 1987-02-10 Medtronic, Inc. Cardioversion and defibrillation lead method
US5111811A (en) * 1985-06-20 1992-05-12 Medtronic, Inc. Cardioversion and defibrillation lead system with electrode extension into the coronary sinus and great vein
US4690155A (en) * 1985-07-03 1987-09-01 Cordis Corporation Monophasic action potential recording lead
DE3633803C2 (en) * 1985-10-22 1995-10-19 Telectronics Nv Defibrillator electrode
US4662377A (en) * 1985-11-07 1987-05-05 Mieczyslaw Mirowski Cardioverting method and apparatus utilizing catheter and patch electrodes
US5330520A (en) * 1986-05-15 1994-07-19 Telectronics Pacing Systems, Inc. Implantable electrode and sensor lead apparatus
DE3640033A1 (en) * 1986-11-24 1988-05-26 Siemens Ag Pacemaker electrode
US4827932A (en) * 1987-02-27 1989-05-09 Intermedics Inc. Implantable defibrillation electrodes
EP0293499B1 (en) * 1987-06-01 1993-09-01 Siemens-Elema AB Implantable multi-pole coaxial lead
DD269095A1 (en) * 1987-12-21 1989-06-21 Dresden Ultraschalltech APPLICATION METHOD FOR ELECTRICALLY CONDUCTIVE POLYAETHYLENE FOR RING ELECTRODE TRANSVENOESIC ELECTRODE CATHETER
US4972846A (en) * 1989-01-31 1990-11-27 W. L. Gore & Associates, Inc. Patch electrodes for use with defibrillators
US4985296A (en) * 1989-03-16 1991-01-15 W. L. Gore & Associates, Inc. Polytetrafluoroethylene film
US5087242A (en) * 1989-07-21 1992-02-11 Iomed, Inc. Hydratable bioelectrode
US5111812A (en) * 1990-01-23 1992-05-12 Cardiac Pacemakers, Inc. Defilbrillation electrode having smooth current distribution
US5115818A (en) * 1990-02-14 1992-05-26 Medtronic, Inc. Implantable electrode
EP0491979A1 (en) * 1990-12-22 1992-07-01 Peter Dr. Ing. Osypka Pacemaker catheter with two poles
US5165403A (en) * 1991-02-26 1992-11-24 Medtronic, Inc. Difibrillation lead system and method of use
US5191901A (en) * 1991-08-29 1993-03-09 Mieczyslaw Mirowski Controlled discharge defibrillation electrode

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH656313A5 (en) * 1982-05-24 1986-06-30 Straumann Inst Ag Electrode with an electrical conductor which is connected to a contact provided for forming a connection with tissue
DE3305271A1 (en) * 1983-02-16 1984-08-16 Siemens AG, 1000 Berlin und 8000 München ELECTRODE ARRANGEMENT
US5016646A (en) * 1988-11-29 1991-05-21 Telectronics, N.V. Thin electrode lead and connections
US5148806A (en) * 1988-12-23 1992-09-22 Yasuhiro Fukui Electrode for use with a living body
US5090422A (en) * 1990-04-19 1992-02-25 Cardiac Pacemakers, Inc. Implantable electrode pouch

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
K. STOKES: "Implantable Pacing Lead Technology", IEEE ENGINEERING IN MEDICINE AND BIOLOGY MAGAZINE, vol. 9, no. 2, June 1990 (1990-06-01), NEW YORK US, pages 43 - 49 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571159A (en) * 1994-04-04 1996-11-05 Alt; Eckhard Temporary atrial defibrillation catheter and method
US5861023A (en) * 1997-12-16 1999-01-19 Pacesetter, Inc. Thrombus and tissue ingrowth inhibiting overlays for defibrillator shocking coil electrodes
US8075969B2 (en) 2000-10-20 2011-12-13 Cathrx Ltd Electrical lead
US7625617B1 (en) 2000-10-20 2009-12-01 Cathrx Ltd Electrical lead
US7629015B2 (en) 2000-10-20 2009-12-08 Cathrx Ltd Method of manufacturing an electrical lead
WO2002032497A1 (en) * 2000-10-20 2002-04-25 Advanced Metal Coatings Pty Limited An electrical lead
US8286338B2 (en) 2004-08-05 2012-10-16 Cathrx Ltd Process of manufacturing a medical use electrical lead
US10668275B2 (en) 2004-08-05 2020-06-02 Cathrx Ltd Electrical leads for medical use
US8903511B2 (en) 2005-06-10 2014-12-02 Cardiac Pacemakers Inc. Lead assembly with porous polyethylene cover
EP2158936A3 (en) * 2008-07-05 2011-02-16 Peter Osypka Medicinal catheter with several poles or electrodes
US8649878B2 (en) 2009-06-19 2014-02-11 Greatbatch Ltd. Temporary stimulation lead with polymer electrodes and method of manufacture
US8825177B2 (en) 2009-06-19 2014-09-02 Greatbatch Ltd. Temporary stimulation lead with polymer electrodes and method of manufacture
EP3181188A1 (en) * 2015-12-15 2017-06-21 BIOTRONIK SE & Co. KG Extendable eclectrode
US10426948B2 (en) 2015-12-15 2019-10-01 Biotronik Se & Co. Kg Extendable electrode

Also Published As

Publication number Publication date
CA2152604A1 (en) 1994-08-18
CA2152604C (en) 2000-05-09
JPH08505539A (en) 1996-06-18
US5609622A (en) 1997-03-11
DE69326080T2 (en) 2000-03-09
EP0681494A1 (en) 1995-11-15
EP0681494B1 (en) 1999-08-18
DE69326080D1 (en) 1999-09-23

Similar Documents

Publication Publication Date Title
US5609622A (en) Implantable electrode with conductive polytetrafluoroethylene elecrode
JP3447737B2 (en) Electrophysiological lead for implants
US7835802B2 (en) Polymer lead covering with varied material properties
JP6517856B2 (en) Embeddable lead
US5554176A (en) Implantable electrode and sensor lead apparatus
US7756589B2 (en) Conductive polymer sheath on defibrillator shocking coils
US5330520A (en) Implantable electrode and sensor lead apparatus
US5741319A (en) Biocompatible medical lead
US7149585B2 (en) Lead body and method of lead body construction
US5861023A (en) Thrombus and tissue ingrowth inhibiting overlays for defibrillator shocking coil electrodes
US9095702B2 (en) Lead assembly and related methods
US9265936B2 (en) Lead assembly and related methods
WO2010056446A1 (en) Eptfe fill of coil filar gaps

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA DE GB JP SE

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2152604

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1993916575

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1993916575

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1993916575

Country of ref document: EP